Advertisement

Topics

Companies Related to "Shire claims approval slow cooked ADHD drug" [Most Relevant Company Matches] RSS

21:22 EDT 21st September 2018 | BioPortfolio

Here are the most relevant search results for "Shire claims approval slow cooked ADHD drug" found in our extensive corporate database of over 50,000 company records.

Showing "Shire claims approval slow cooked ADHD drug" Companies 1–25 of 3,900+

Extremely Relevant

Shire Ltd.

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the ...


Shire Ltd

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Sh...

Relevant

Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company’s extensive expertise in product development has been built over the past 20 years: initially as a stand alone development organization, then as a U.S. subsid...


CHADD

CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder) is the leading resource on attention-deficit/hyperactivity disorder (ADHD), providing support, training, education and advocacy for the 17 million children and adults in the United States living with ADHD, their families, educators and healthcare professionals. As home to the Nationa...

Shire plc

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is focused on developing specialty CNS products designed to address unmet medical needs. The company’s portfolio is well diversified with its two lead products Epliga® and Trokesa® for the treatment of epilepsy approaching NDA filings, followed by three products in the ADHD area, SPN810 and SPN812 in Phase II and S...

Highland Therapeutics Inc.

Highland Therapeutics Inc. is a specialty pharmaceutical company that, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc., is leveraging its proprietary technology, DELEXIS™, to optimize the delivery of previously approved drug products. The Company’s lead product candidates, HLD-200 and HLD-100, are novel formulati...

Shire

Founded in 1986, Shire plc is a global specialty pharmaceutical company with revenues for the full year 2005 of $1,599.3 million and an operating income of $(354.1) million. The growth rates for revenues were 17% for 2005 over the prior year. The Shire MissionShire’s mission is to develop and market medicines that improve the quality of life for patients and their caregivers. We do so through th...

BioDelivery Sciences International

We are a specialty pharmaceutical company that is exploiting its licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics. Our development strategy focuses on the utilization of the FDA’s 505(b)(2) approval process to obtain more timely and eff...

BioBehavioral Diagnostics Company

BioBehavioral Diagnostics Company manufactures and markets the Quotient(TM) ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptoms. We are dedicated to providing physicians, parents and patients with high-value information to guide personalized strategies and to enhance quality of life for patients with ADHD. Our vision is to provide accurate tools for the diagnosi...

Pacific BioDevelopment, LLC.

Our mission at Pacific BioDevelopment is to provide the highest quality integrated drug development strategies in order to facilitate timely and cost efficient proof-of-concept results, entry into the clinic, or market approval. Our goal is to develop long term relationships with each client by providing comprehensive drug development strategies designed to accelerate time to approval. Since 1997,...

Able Labs Incorporated

Able Laboratories, Inc. is a rapidly growing developer and manufacturer of generic pharmaceuticals in tablet, capsule and suppository dosage forms. Able's focus is to develop products that offer attractive market opportunities within selected niche markets of the generic drug industry. In addition to one New Drug Application approval (NDA), the company received 13 Abbreviated New Drug Application ...

Kemberton

Kemberton is a proven leader in tackling motor vehicle accident (MVA) and other complex claims challenges. As a byproduct of the company’s specialized revenue cycle management services, Kemberton has been advocating for hospitals and patients for almost a decade to improve claims reimbursement. The company applies the latest in claims workflow auto...

Shire Limited

Crawford & Company

Based in Atlanta, Ga., Crawford & Company (www.crawfordandcompany.com) is the world's largest independent provider of claims management solutions to the risk management and insurance industry as well as self-insured entities, with a global network of more than 700 locations in 63 countries. The Crawford System of Claims Solutions(SM) offers comprehensive, integrated claims services, business proce...

NLS Pharma

NLS/NLS-1 Pharma (NLS) – NLS is a Swiss based biotech group focusing on the repurposing of established and (cost-) effective drug/chemical compounds to treat Attention Deficit/HyperActivity Disorder (ADHD), sleep disorders and cognitive impairment.

The Drug & Device Development Co., Inc

The Drug & Device Development Co., Inc. founded in 1985, has expertise in the regulatory, clinical, quality and statistical aspects of drug, biologic, diagnostic, and medical device development. The DDD group consists of both full-time and part-time specialists. Each one is well experienced in one or more aspects of the drug, biologic and/or device approval process.The major focus of DDD's service...

Kurve Technology, Inc

Kurve Technology offers pharmaceutical companies a versatile, cost-effective and compact nasal drug delivery devices for local and systemic medical therapies. Invented by a long-time sinusitis and allergy-sufferer, Kurve’s nasal drug delivery technologies offer an effective way to deliver both small and large molecule formulations. Controlled Particle Dispersion is patent-pending, with initial a...

GenSpera, Inc.

GenSpera, Inc. is a development stage oncology company focused on therapeutics that deliver a potent, unique and patented drug directly to tumors. GenSpera’s technology platform combines a potent cytotoxin (12ADT) with a pro-drug delivery system that activates the drug only within the tumor. Unlike standard cancer drugs, plant-derived 12ADT kills cell...

McNeil Pediatrics(TM)

McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is committed to meeting the needs of children, adolescents, adults and healthcare professionals through the development of therapies specifically formulated for children, adolescents and adults. McNeil Pediatrics(TM) is a leader in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and markets a leading me...

Shire Pharmaceuticals

Bev Volpe (bvolpe@simonpr.com)

NextWave Pharmaceuticals

NextWave is an emerging specialty pharmaceutical company primarily focused on the development and commercialization of unique products for the treatment of cardiovascular and CNS diseases, with a pipeline of investigational drug candidates targeted for ADHD and related disorders. More information about NextWave is available at www.nextwavepharma.com.

CBSET Inc.

CBSET Inc., 500 Shire Way, Lexington, MA 02421 — is the preclinical research leader in critically important therapeutic fields such as interventional cardiology, renal disease and dialysis, chronic drug-resistant hypertension, women’s health, minimally invasive surgery, orthopedics, biological and synthetic tissue repair, drug delivery, bioresorb...

Crawford and Co.

Based in Atlanta, Georgia, Crawford & Company (www.crawfordandcompany.com) is the world's largest independent provider of claims management and related solutions to the risk management and insurance industry as well as self-insured entities, with a global network of more than 700 locations in 63 countries. Major service lines include property and casualty claims management; warranty inspections; i...

Naryx Pharma, Inc.

Naryx Pharma is a specialty pharmaceutical company that is developing promising propriety medication formulations for the FDA approval process. Naryx Pharma is focused on development of its product candidates of inhaled, nebulized, intranasal drug formulations. The approvals will enable Naryx Pharma to market and distribute formulations that will fulfill an unmet medical need for the treatment of ...


More From BioPortfolio on "Shire claims approval slow cooked ADHD drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks